Figure 1From: Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma Kaplan-Meier estimates of overall survival (A) and progression-free survival (B) for the 163 relapsed/primary refractory DLBCL patients stratified by second-line age-adjusted International Prognostic Index (saaIPI) are shown. Back to article page